Pharmaceutical company Pneuma Respiratory Inc revealed on Friday the addition of shareholder J. Knox Singleton to its board of directors.
Singleton has served for 35 years as the CEO of Inova Health System, the largest employer in Northern Virginia, until his retirement in July 2018.
Previously, Singleton received numerous awards during his career in recognition of his leadership in the field of health care.
According to the company, Singleton is a Phi Beta Kappa graduate of the University of North Carolina, where he earned a Bachelor of Science Degree in Business Administration and he holds a Master's Degree in Health Administration from Duke University.
IDEAYA Biosciences submits IND for IDE892; Targets Phase 1 in 4Q 2025
Airiver medical receives FDA approval for central airway stenosis trial
Calluna Pharma begins Phase 2 study of CAL101 in idiopathic pulmonary fibrosis
Coya Therapeutics wins FDA clearance to advance COYA 302 into Phase 2 ALS trial
Innovent Biologics receives approval over squamous cell lung cancer study
Novocure submits FDA PMA for Tumor Treating Fields therapy in pancreatic cancer
HUTCHMED completes enrollment in Phase III SANOVO trial of ORPATHYS and TAGRISSO in China